Adage Capital Partners
CGON icon

Adage Capital Partners’s CG Oncology CGON Stock Holding History

Adage Capital Partners’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7M Sell
390,458
-9,400
-2% -$614K 0.04% 411
2026
Q1 		$27.1M Buy
+399,858
New +$22.7M 0.04% 390
2025
Q1 		– Sell
-200,000
Closed -$5.74M – 859
2024
Q4 		$5.74M Sell
200,000
-200,000
-50% -$6.84M 0.01% 701
2024
Q3 		$15.1M Buy
400,000
+70,000
+21% +$2.45M 0.03% 525
2024
Q2 		$10.4M Sell
330,000
-125,000
-27% -$4.33M 0.02% 601
2024
Q1 		$20M Buy
+455,000
New +$18.6M 0.04% 452

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners's CGON Position: Q2 2026 in Review

Adage Capital Partners reduced its CG Oncology (CGON) stake by 2.4% in Q2 2026, selling an estimated $614K and leaving 390,458 shares worth $27.7M. The position accounts for 0.04% of the portfolio, ranked #411.

Adage Capital Partners first reported a position in CGON in Q1 2024 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Adage Capital Partners held 390,458 shares of CG Oncology worth $27.7M as of Q2 2026.
  • Adage Capital Partners sold 9,400 CG Oncology shares in Q2 2026, an estimated $614K.
  • CG Oncology made up 0.04% of Adage Capital Partners's portfolio in Q2 2026, its #411 holding.
  • Adage Capital Partners first reported a position in CG Oncology in Q1 2024 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.